{"disease":{"id":"adenocarcinoma-of-the-prostate","name":"adenocarcinoma of the prostate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01949337","title":"Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":1311,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":true},{"nct_id":"NCT03686683","title":"Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":532,"lead_sponsor_name":"Dendreon","has_results":true},{"nct_id":"NCT04909957","title":"Prediction of Lymph Node Invasion for Prostate Adenocarcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT02296229","title":"Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02761889","title":"Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Fundacao Champalimaud","has_results":false},{"nct_id":"NCT04028479","title":"The Registry of Oncology Outcomes Associated With Testing and Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Taproot Health","has_results":false},{"nct_id":"NCT03517488","title":"A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Xencor, Inc.","has_results":false},{"nct_id":"NCT04586543","title":"Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"László Mangel","has_results":false},{"nct_id":"NCT02176902","title":"Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":107,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02203695","title":"Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT04909294","title":"Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":68,"lead_sponsor_name":"Centre Georges Francois Leclerc","has_results":false},{"nct_id":"NCT03535675","title":"Muscadine Plus (MPX) In Men With Prostate Cancer","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":59,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT01117935","title":"Intensity-Modulated External Beam Radiation Therapy in Treating Patients With Prostate Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Virginia Commonwealth University","has_results":false},{"nct_id":"NCT01807065","title":"Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"City of Hope Medical Center","has_results":true},{"nct_id":"NCT02523924","title":"Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT01517451","title":"Radiation and Androgen Ablation for Prostate Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":true},{"nct_id":"NCT01655836","title":"High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":false},{"nct_id":"NCT01927627","title":"Enzalutamide in Patients With High-risk Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":true},{"nct_id":"NCT01094288","title":"A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Millennium Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT01912820","title":"Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT02217709","title":"Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT02023463","title":"Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":25,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT01093183","title":"Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":25,"lead_sponsor_name":"University of Nebraska","has_results":true},{"nct_id":"NCT02278185","title":"Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"University of Colorado, Denver","has_results":true},{"nct_id":"NCT02064036","title":"Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"University of California, Davis","has_results":false},{"nct_id":"NCT03077659","title":"Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"NanOlogy, LLC","has_results":true},{"nct_id":"NCT02163317","title":"Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT01126879","title":"Genistein in Treating Patients With Prostate Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT01992016","title":"A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"University of Colorado, Denver","has_results":true},{"nct_id":"NCT01498978","title":"Ipilimumab in Combination With Androgen Suppression Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"OHSU Knight Cancer Institute","has_results":true},{"nct_id":"NCT01848067","title":"Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":true},{"nct_id":"NCT01703065","title":"Cabozantinib in Men With Castration-Resistant Prostate Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT02048150","title":"Intra-operative Optical Imaging With MDX1201-A488 in Patients With Prostate Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT01866423","title":"Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"University of Southern California","has_results":true},{"nct_id":"NCT02234921","title":"Pilot Study of DRibble Vaccine for Prostate Cancer Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":3,"lead_sponsor_name":"UbiVac","has_results":false},{"nct_id":"NCT03432897","title":"BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Brown University","has_results":true}],"total":36},"guidelines":[],"source":"Drug Landscape verified database"}